These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 37532274)
1. A novel miRNA-based signature as predictive tool of survival outcome of colorectal cancer patients. Zhao B; Wang W; Ye H; Wang J; Meng K; Yang T Chem Biol Drug Des; 2023 Nov; 102(5):1024-1033. PubMed ID: 37532274 [TBL] [Abstract][Full Text] [Related]
2. A Panel of MicroRNA Signature as a Tool for Predicting Survival of Patients with Urothelial Carcinoma of the Bladder. Inamoto T; Uehara H; Akao Y; Ibuki N; Komura K; Takahara K; Takai T; Uchimoto T; Saito K; Tanda N; Yoshikawa Y; Minami K; Hirano H; Nomi H; Kato R; Hayashi T; Azuma H Dis Markers; 2018; 2018():5468672. PubMed ID: 30026881 [TBL] [Abstract][Full Text] [Related]
3. Integrated Analysis Identifies a Nine-microRNA Signature Biomarker for Diagnosis and Prognosis in Colorectal Cancer. Di Z; Di M; Fu W; Tang Q; Liu Y; Lei P; Gu X; Liu T; Sun M Front Genet; 2020; 11():192. PubMed ID: 32265979 [TBL] [Abstract][Full Text] [Related]
4. Development of a necroptosis-related prognostic model for uterine corpus endometrial carcinoma. Zhang Q; Luo Y; Zhang S; Huang Q; Liu G Sci Rep; 2024 Feb; 14(1):4257. PubMed ID: 38383747 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA signature for estimating the survival time in patients with bladder urothelial carcinoma. Yerukala Sathipati S; Tsai MJ; Shukla SK; Ho SY; Liu Y; Beheshti A Sci Rep; 2022 Mar; 12(1):4141. PubMed ID: 35264666 [TBL] [Abstract][Full Text] [Related]
6. A Five-microRNA Signature as Prognostic Biomarker in Colorectal Cancer by Bioinformatics Analysis. Yang G; Zhang Y; Yang J Front Oncol; 2019; 9():1207. PubMed ID: 31799184 [TBL] [Abstract][Full Text] [Related]
7. Prognostic microRNA signature for estimating survival in patients with hepatocellular carcinoma. Yerukala Sathipati S; Aimalla N; Tsai MJ; Carter T; Jeong S; Wen Z; Shukla SK; Sharma R; Ho SY Carcinogenesis; 2023 Dec; 44(8-9):650-661. PubMed ID: 37701974 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA Expression Profiling on Paired Primary and Lymph Node Metastatic Breast Cancer Revealed Distinct microRNA Profile Associated With LNM. Elango R; Alsaleh KA; Vishnubalaji R; Manikandan M; Ali AM; Abd El-Aziz N; Altheyab A; Al-Rikabi A; Alfayez M; Aldahmash A; Alajez NM Front Oncol; 2020; 10():756. PubMed ID: 32509578 [TBL] [Abstract][Full Text] [Related]
9. Analysis of differential expression profile of miRNA in peripheral blood of patients with lung cancer. He Q; Fang Y; Lu F; Pan J; Wang L; Gong W; Fei F; Cui J; Zhong J; Hu R; Liang M; Fang L; Wang H; Yu M; Zhang ZF J Clin Lab Anal; 2019 Nov; 33(9):e23003. PubMed ID: 31541491 [TBL] [Abstract][Full Text] [Related]
10. Establishing a three-miRNA signature as a prognostic model for colorectal cancer through bioinformatics analysis. Wang Y; Huang L; Shan N; Ma H; Lu S; Chen X; Long H Aging (Albany NY); 2021 Aug; 13(15):19894-19907. PubMed ID: 34388112 [TBL] [Abstract][Full Text] [Related]
11. A Novel Necroptosis-Related miRNA Signature for Predicting the Prognosis of Breast Cancer Metastasis. Zheng L; Wang J; Jiang H; Dong H Dis Markers; 2022; 2022():3391878. PubMed ID: 35371342 [TBL] [Abstract][Full Text] [Related]
12. Development of an miRNA-Array-Based Diagnostic Signature for Periodontitis. Jin SH; Zhou JG; Guan XY; Bai GH; Liu JG; Chen LW Front Genet; 2020; 11():577585. PubMed ID: 33391341 [TBL] [Abstract][Full Text] [Related]
13. Systematic analyses of a novel circRNA-related miRNAs prognostic signature for Cervical Cancer. Wang S; Zhang S Genet Mol Biol; 2022; 45(2):e20210405. PubMed ID: 35766420 [TBL] [Abstract][Full Text] [Related]
14. Survival associated miRNA signature in patients with head and neck carcinomas. Yerukala Sathipati S; Ho SY Heliyon; 2023 Jun; 9(6):e17218. PubMed ID: 37360084 [TBL] [Abstract][Full Text] [Related]
15. A Novel Defined Necroptosis-Related miRNAs Signature for Predicting the Prognosis of Colon Cancer. Yang Z; Lu S; Wang Y; Tang H; Wang B; Sun X; Qu J; Rao B Int J Gen Med; 2022; 15():555-565. PubMed ID: 35046713 [TBL] [Abstract][Full Text] [Related]
16. Experimental validation of in silico analysis estimated the reverse effect of upregulated hsa-miR-106a-5p and hsa-miR-223-3p on SLC4A4 gene expression in Iranian patients with colorectal adenocarcinoma by RT-qPCR. Ranjbaran J; Safarpour H; Nomiri S; Tavakoli T; Rezaei Z; Salmani F; Larki P; Chamani E Cancer Med; 2023 Mar; 12(6):7005-7018. PubMed ID: 36468451 [TBL] [Abstract][Full Text] [Related]
17. An evaluation and replication of miRNAs with disease stage and colorectal cancer-specific mortality. Slattery ML; Herrick JS; Mullany LE; Valeri N; Stevens J; Caan BJ; Samowitz W; Wolff RK Int J Cancer; 2015 Jul; 137(2):428-38. PubMed ID: 25484364 [TBL] [Abstract][Full Text] [Related]
18. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer. Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K Front Immunol; 2022; 13():947802. PubMed ID: 36405735 [TBL] [Abstract][Full Text] [Related]
19. Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis. Zhang JX; Song W; Chen ZH; Wei JH; Liao YJ; Lei J; Hu M; Chen GZ; Liao B; Lu J; Zhao HW; Chen W; He YL; Wang HY; Xie D; Luo JH Lancet Oncol; 2013 Dec; 14(13):1295-306. PubMed ID: 24239208 [TBL] [Abstract][Full Text] [Related]
20. A data-driven biocomputing pipeline with meta-analysis on high throughput transcriptomics to identify genome-wide miRNA markers associated with type 2 diabetes. De Silva K; Demmer RT; Jönsson D; Mousa A; Forbes A; Enticott J Heliyon; 2022 Feb; 8(2):e08886. PubMed ID: 35169647 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]